45.43

1.77% -0.82

After Hours: 45.43

Janux Therapeutics Inc (JANX)

Overview News Price History Option Chain Financials Discussions Forecast

Janux Therapeutics Inc stock is traded at $45.43, with a volume of 878.26K. It is down -1.77% in the last 24 hours and down -3.30% over the past month. Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.

Previous Close:

$46.25

Open:

$45.46

24h Volume:

878.26K

Relative Volume:

1.52

Market Cap:

$2.43B

Revenue:

$15.13M

Net Income/Loss:

$-44.05M

P/E Ratio:

-27.87

EPS:

-1.63

Net Cash Flow:

$-47.75M

1W Performance:

-9.61%

1M Performance:

-3.30%

6M Performance:

+20.66%

1Y Performance:

+350.69%

1-Day Range:

$44.33

$47.02

1-Week Range:

$44.33

$51.71

52-Week Range:

$5.65

$65.60

Janux Therapeutics Inc Stock (JANX) Company Profile

Name

Janux Therapeutics Inc

Sector

Healthcare (1203)

Industry

Biotechnology (681)

Phone

(858) 751-4493

Address

10955 VISTA SORRENTO PARKWAY, SAN DIEGO

Employee

Twitter

Next Earnings Date

2024-08-06

Latest SEC Filings

JANX's Discussions on Twitter

Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-06-23	Initiated	Wedbush	Outperform
Nov-14-22	Initiated	William Blair	Outperform

Janux Therapeutics Inc Stock (JANX) Latest News

01:43 AM

Daily Progress: Janux Therapeutics Inc (JANX) Drop -0.79, Closing at 46.25 - The Dwinnex

01:43 AM

Sep 28, 2024

Janux Therapeutics, Inc. (NASDAQ:JANX) CEO Sells $1,157,750.00 in Stock - MarketBeat

Sep 28, 2024

Blue Owl Capital Holdings LP Makes New $1.68 Million Investment in Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat

Sep 28, 2024

Insider Sale: Chief Business Officer Andrew Meyer Sells 50,000 S - GuruFocus.com

Sep 28, 2024

Sep 27, 2024

Janux therapeutics executive sells $2.3 million in stock By Investing.com - Investing.com South Africa

Sep 27, 2024

Janux therapeutics executive sells $2.3 million in stock - Investing.com India

Sep 27, 2024

Janux Therapeutics CEO sells over $1.15 million in company stock By Investing.com - Investing.com Australia

Sep 27, 2024

Janux therapeutics executive sells $2.3 million in stock - Investing.com

Sep 27, 2024

Janux Therapeutics exec sells over $230k in company stock - Investing.com

Sep 27, 2024

Janux Therapeutics CEO sells over $1.15 million in company stock - Investing.com

Sep 27, 2024

Get in on Janux Therapeutics Inc’s (JANX) buy-in window today! - SETE News

Sep 27, 2024

Taking a look at what insiders are doing to gauge the Janux Therapeutics Inc (JANX)’s direction - Knox Daily

Sep 27, 2024

Sep 26, 2024

Is Janux Therapeutics Inc. (JANX) the Best Performing Small-Cap Stock in 2024? - Insider Monkey

Sep 26, 2024

Is Janux Therapeutics Inc. (JANX) the Best Performing Small-Cap Stock in 2024? - Yahoo Finance

Sep 26, 2024

Profund Advisors LLC Invests $598,000 in Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat

Sep 26, 2024

Sep 25, 2024

10 Best Performing Small-Cap Stocks in 2024 - Insider Monkey

Sep 25, 2024

Sep 24, 2024

Samlyn Capital LLC Purchases 28,312 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

Sep 24, 2024

Logos Global Management LP Grows Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

Sep 24, 2024